RankingsPricing
  1. JP-listed companies
  2. OncoTherapy Science, Inc.
  3. Financials
  4. Income before tax

OncoTherapy Science, Inc.【JP:4564】

Market cap
¥6.7B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 2025-815-28.28%
Mar 31, 2024-1,136+0.29%
Mar 31, 2023-1,133-45.31%
Mar 31, 2022-2,072+26.39%
Mar 31, 2021-1,639-25.39%
Mar 31, 2020-2,197-25.75%
Mar 31, 2019-2,959-0.61%
Mar 31, 2018-2,977-1.05%
Mar 31, 2017-3,009+1.54%
Mar 31, 2016-2,963+52.74%
Mar 31, 2015-1,940-48.51%
Mar 31, 2014-3,768+238.22%
Mar 31, 2013-1,114-188.70%
Mar 31, 20121,256

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)